Narcotics Schedule: Classifications, Penalties, and Analogues

Federal law places every controlled substance into one of five categories called schedules, ranked by how likely the drug is to be abused and whether it has an accepted medical use. Schedule I is the most restrictive and carries the harshest criminal penalties; Schedule V is the least restrictive. Distribution penalties range from up to one year in prison at the bottom to up to 20 years (or life, when a death results) at the top, while simple possession of any scheduled drug without a prescription is a federal crime regardless of where the substance sits. The framework comes from the Controlled Substances Act, codified in Title 21 of the United States Code, which gives the Attorney General authority to add, move, or remove substances.¹ Here is what sits on each schedule and what the penalties look like.

How a Drug Lands on a Schedule

Scheduling is a joint effort between the Drug Enforcement Administration and the Department of Health and Human Services. HHS evaluates the science and medicine; the DEA makes the final legal classification.² The decision turns on a drug’s potential for abuse, whether it has an accepted medical use in the United States, and how severely it causes dependence. International treaty obligations can also force a scheduling decision regardless of the domestic analysis.¹

Schedule I

Schedule I is reserved for substances with a high potential for abuse, no accepted medical use in the United States, and no accepted safety for use even under medical supervision.³ Because of the “no accepted medical use” prong, doctors cannot prescribe these drugs and pharmacies do not stock them.

Common examples include heroin, LSD, psilocybin, and MDMA (ecstasy). Marijuana has historically been classified here as well, though its status is actively changing (see below). The only lawful way to work with Schedule I substances is through government-approved research, which requires a detailed protocol submitted to the DEA covering the study’s purpose, quantities, security, and investigator qualifications.⁴

A first offense for manufacturing or distributing a Schedule I substance carries up to 20 years in federal prison. If someone dies or suffers serious bodily injury from the distributed drug, the minimum jumps to 20 years and the maximum is life.⁵ Large-quantity offenses involving specific drugs trigger mandatory minimums of five or ten years.

Schedule II

Schedule II drugs share Schedule I’s high abuse potential but have an accepted medical use, usually with heavy restrictions. Abuse can lead to severe physical or psychological dependence.³ Most of the powerful prescription painkillers live here: oxycodone, fentanyl, hydromorphone, methadone, morphine, and high-concentration codeine formulations. Stimulants like amphetamine (Adderall) and methylphenidate (Ritalin) are also on this schedule, as is methamphetamine.

Prescribing rules are tight. Refills are flatly prohibited; a patient needs a new prescription each time. A doctor may issue multiple prescriptions at one visit covering up to a 90-day supply, but each must carry a “do not fill until” date and the prescriber must determine the arrangement does not create an undue risk of diversion.⁶

Distribution penalties mirror Schedule I: up to 20 years for a first offense without aggravating factors, with mandatory minimums for large quantities or where someone dies.⁵

Schedule III

Schedule III is a meaningful step down. These substances have a lower abuse potential than Schedule I or II, an accepted medical use, and misuse tends to produce moderate or low physical dependence, though psychological dependence can still run high.³ Ketamine, anabolic steroids, and combination products with limited codeine (less than 90 milligrams per dose, such as some Tylenol with Codeine preparations) sit here. Testosterone and other anabolic steroids were placed here because of widespread misuse in athletics, despite their legitimate medical applications.

A Schedule III prescription can be refilled up to five times and remains valid for six months from the date written.⁷ After either limit is hit, the patient needs a new prescription.

Illegal distribution of a Schedule III substance carries up to 10 years in prison for a first offense, or up to 15 years if someone dies or suffers serious bodily injury from the drug.⁵

Schedule IV

Schedule IV substances have a low abuse potential relative to Schedule III, an accepted medical use, and produce only limited dependence when misused.³ The benzodiazepine family dominates this schedule: alprazolam (Xanax), diazepam (Valium), lorazepam (Ativan), and clonazepam (Klonopin). The sleep medication zolpidem (Ambien) is also here.

The same refill rules as Schedule III apply: up to five refills within six months of the original prescription date.⁷ The lower classification does not make these drugs risk-free; benzodiazepine misuse has been a major driver of overdose deaths when combined with opioids.

Illegal distribution of a Schedule IV drug carries up to five years in prison and fines of up to $250,000 for an individual.⁵

Schedule V

Schedule V holds the lowest-risk controlled substances: lowest abuse potential, accepted medical uses, and minimal dependence risk.³ These are typically preparations containing small amounts of narcotics blended with non-narcotic ingredients, used for coughs, diarrhea, or mild pain. A cough syrup with no more than 200 milligrams of codeine per 100 milliliters is the classic example.

Federal regulations let pharmacists dispense certain Schedule V products without a prescription if conditions are met. The buyer must be at least 18, show identification if the pharmacist does not know them, and the pharmacist must record the transaction in a bound logbook. No more than 8 ounces of an opium-containing product or 4 ounces of another controlled substance can be sold to any one person in a 48-hour period.⁸ State rules are often tighter than this federal floor, so availability varies.

Illegal distribution of a Schedule V substance carries up to one year in prison and fines of up to $100,000 for an individual.⁵

Possession Penalties Do Not Vary by Schedule

Distribution penalties step down sharply from Schedule I to Schedule V, but possession penalties do not. Simple possession of any controlled substance without a valid prescription is a federal crime, and the penalty structure is the same whether the drug is heroin or a Schedule V cough preparation. A first offense carries up to one year in prison and a minimum fine of $1,000. A second offense carries 15 days to two years and a $2,500 minimum fine. A third or subsequent offense carries 90 days to three years and a $5,000 minimum fine.⁹

For personal-use quantities, the government can pursue a civil penalty instead of criminal charges. The civil fine maxes out at $10,000 per violation and can be assessed no more than twice for any individual. It is unavailable to anyone with a prior drug conviction.¹⁰ The criminal track remains the default in most federal cases.

Enhancements can push distribution penalties well beyond the baseline numbers above. Large quantities trigger mandatory minimums. Firearms involvement adds time. An overdose death linked to the distributed substance can convert a 10- or 20-year maximum into a mandatory 20-to-life sentence.⁵

Analogues Are Treated as Schedule I

The five-schedule system has an obvious gap: a chemist can modify a molecule just enough to produce a substance that is not technically listed anywhere but behaves like a scheduled drug. The Federal Analogue Act closes it. A substance qualifies as a “controlled substance analogue” if its chemical structure is substantially similar to a Schedule I or II drug and it produces a substantially similar stimulant, depressant, or hallucinogenic effect, or is represented or intended to do so.¹¹ The substance must also be intended for human consumption. Once an analogue meets the criteria, federal law treats it as a Schedule I drug for prosecution and sentencing.¹² This provision has been central to federal prosecutions of synthetic cannabinoids, bath salts, and illicitly manufactured fentanyl analogues.

Emergency Scheduling

The standard scheduling process takes time. When a new substance poses an immediate threat, the Attorney General can bypass most of it and temporarily place the drug in Schedule I by emergency order.¹ The Attorney General must publish notice in the Federal Register at least 30 days before the order takes effect. Temporary placement lasts two years and can be extended by one additional year while permanent scheduling proceedings run. These orders are not subject to judicial review. The DEA has used this authority repeatedly to ban novel synthetic drugs before the full administrative process can catch up.

Marijuana’s Shifting Federal Status

Marijuana’s placement in Schedule I has been one of the most debated features of the system for decades, and in 2026 its federal status is actively changing. The Justice Department and DEA issued an order placing both FDA-approved marijuana products and marijuana products regulated under state medical programs into Schedule III.¹³ The DEA has also initiated an expedited administrative hearing process, beginning June 29, 2026, to consider broader rescheduling of marijuana from Schedule I to Schedule III.

If marijuana is fully reclassified to Schedule III, criminal penalties for distribution would drop from the 20-year maximum tied to Schedule I down to the 10-year maximum for Schedule III. Doctors in states with medical marijuana programs could potentially prescribe it under the same framework as other Schedule III drugs. The federal tax code provision that currently blocks state-legal cannabis businesses from deducting ordinary business expenses, which applies only to Schedule I and II substances, would no longer apply.

Marijuana’s legal status remains fractured in the meantime. The Rohrabacher-Blumenauer Amendment, a congressional budget rider that had prohibited the Department of Justice from spending money to interfere with state medical cannabis programs, was not renewed in the most recent federal appropriations bill. The DOJ technically has full enforcement authority against state-legal medical marijuana operations again, though how aggressively it chooses to use that authority is a separate question. Anyone operating in the cannabis space should monitor these developments closely.

1
Office of the Law Revision Counsel. 21 USC 811 – Authority and Criteria for Classification of Substances
2
Drug Enforcement Administration. The Controlled Substances Act
3
Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances
4
eCFR. 21 CFR 1301.18 – Research Protocols
5
Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A
6
eCFR. 21 CFR 1306.12 – Refilling Prescriptions; Issuance of Multiple Prescriptions
7
eCFR. 21 CFR 1306.22 – Refilling of Prescriptions
8
eCFR. 21 CFR 1306.26 – Dispensing Without Prescription
9
Office of the Law Revision Counsel. 21 USC 844 – Penalties for Simple Possession
10
Office of the Law Revision Counsel. 21 USC 844a – Civil Penalty for Possession of Small Amounts of Certain Substances
11
Office of the Law Revision Counsel. 21 USC 802 – Definitions
12
Office of the Law Revision Counsel. 21 USC 813 – Treatment of Controlled Substance Analogues
13
U.S. Department of Justice. Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana